Skip to main content

DCVMN at the GAVI Vaccine Summit together with world leaders to support the COVAX-AMC

gavi_062020.jpg London, 04th June 2020 – Gavi celebrated two decades of improving immunization for children in 73 poor countries, that has prevented millions of deaths, reduced child mortality and increased global health security and sustainability. In the face of the current pandemic, Gavi, the vaccine alliance, is well placed to lead the charge in ensuring availability of potential COVID-19 vaccines for GAVI eligible countries and high-risk populations worldwide. “The COVID-19 AMC is an example of the progressive and decisive actions GAVI has taken to provide an initial framework to tackle this pandemic. The DCVMN constituency supports the COVID-19 Advance Market Commitment (AMC) and calls for equal participation of innovators and manufacturers”, said Sai D. Prasad, DCVMN President, at the Global Vaccine Summit, hosted by United Kingdom Prime Minister, Boris Johnson, gathering over 70 speakers. The livestreamed virtual event saw participation from over 30 heads of state and government, as well as leaders from government, business, civil society and international organizations. The event resulted in the raising of a remarkable US$ 8.8 billion towards the replenishment of Gavi, which the DCVMN commends. Representing a network of manufacturers that have collective experience in supplying over 3.5 billion doses annually to 170 countries, DCVMN members strive to be reliable partners, ready and available to support the Alliance in its response to COVID-19. The DCVMN members’ response to COVID-19 has been rapid and comprehensive: member companies are at the forefront in vaccine development, based on various technology platforms, enabling capabilities for high quality, large scale manufacturing, aimed at supplying global products through local manufacturing, and to leave no one behind. More information at

Attached documents